The role of inducible nitric oxide synthase for interstitial remodeling of alveolar septa in surfactant protein D-deficient mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 9, 2015, Pages L959-L969

  Knudsen, Lars ^a,b   Atochina Vasserman, Elena N ^c   Massa, Christopher B ^d   Birkelbach, Bastian ^a   Guo, Chang Jiang ^d   Scott, Pamela ^d   Haenni, Beat ^e   Beers, Michael F ^c   Ochs, Matthias ^a,b,f   Gow, Andrew J ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF BERN   (Switzerland)

^f REBIRTH Cluster of Excellence   (Germany)

Author keywords

Inducible nitric oxide synthase; Invasive pulmonary function test; Modeling; Stereology; Surfactant protein D

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; SURFACTANT PROTEIN D; NOS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN FIBRIL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG COMPLIANCE; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG INTERSTITIUM; LUNG MECHANICS; MOUSE; NONHUMAN; OSCILLATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; STEREOLOGY; TOTAL LUNG CAPACITY; AIRWAY REMODELING; ANIMAL; BIOLOGICAL MODEL; BREATHING MECHANICS; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

AIRWAY REMODELING; ANIMALS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY MECHANICS;

EID: 84946423000     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00017.2015     Document Type: Article

References (42)

1. Atochina E, Beers M, Hawgood S, Poulain F, Davis C, Fusaro T, Gow A. Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. Am J Respir Cell Mol Biol 30: 271–279, 2004.
2. Atochina E, Gow A, Beck J, Haczku A, Inch A, Kadire H, Tomer Y, Davis C, Preston A, Poulain F, Hawgood S, Beers M. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J Infect Dis 189: 1528–1539, 2004.
3. Atochina-Vasserman E, Beers M, Kadire H, Tomer Y, Inch A, Scott P, Guo C, Gow A. Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice. J Immunol 179: 8090–8097, 2007.
4. Birkelbach B, Lutz D, Ruppert C, Henneke I, Lopez-Rodriguez E, Günther A, Ochs M, Mahavadi P, Knudsen L. Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithe- lial type II cells in the amiodarone mouse model. Am J Physiol Lung Cell Mol Physiol 309: L63–L75, 2015.
5. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillespie A, Epstein C, Hawgood S. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 95: 11869–11874, 1998.
6. Casey J, Kaplan J, Atochina-Vasserman E, Gow A, Kadire H, Tomer Y, Fisher J, Hawgood S, Savani R, Beers M. Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am J Respir Crit Care Med 172: 869–877, 2005.
7. Collins R, Ikegami M, Korfhagen T, Whitsett J, Sly P. In vivo measurements of changes in respiratory mechanics with age in mice deficient in surfactant protein D. Pediatr Res 53: 463–467, 2003.
8. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie Leblond I, Israel Biet D, Court Fortune I, Valeyre D, Cordier JF; Groupe d’Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26: 586–593, 2005.
9. Epaud R, Delestrain C, Louha M, Simon S, Fanen P, Tazi A. Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations. Eur Respir J 43: 638–641, 2014.
10. Gardai S, Xiao Y, Dickinson M, Nick J, Voelker D, Greene K, Henson P. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13–23, 2003.
11. Giri SN, Biring I, Nguyen T, Wang Q, Hyde DM. Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. Nitric Oxide 7: 109–118, 2002.
12. Groves AM, Gow AJ, Massa CB, Hall L, Laskin JD, Laskin DL. Age-related increases in ozone-induced injury and altered pulmonary mechanics in mice with progressive lung inflammation. Am J Physiol Lung Cell Mol Physiol 305: L555–L568, 2013.
13. Groves AM, Gow AJ, Massa CB, Laskin JD, Laskin DL. Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation. Am J Respir Cell Mol Biol 47: 776–783, 2012.
14. Guo C, Atochina-Vasserman E, Abramova E, Foley J, Zaman A, Crouch E, Beers M, Savani R, Gow A. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 6: e266, 2008.
15. Gurujeyalakshmi G, Wang Y, Giri SN. Suppression of bleomycininduced nitric oxide production in mice by taurine and niacin. Nitric Oxide 4: 399–411, 2000.
16. Hantos Z, Daróczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72: 168–178, 1992.
17. Hsia CC, Hyde DM, Ochs M, Weibel ER. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 181: 394–418, 2010.
18. Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 141: 222–231, 2012.
19. Janssen W, McPhillips K, Dickinson M, Linderman D, Morimoto K, Xiao Y, Oldham K, Vandivier R, Henson P, Gardai S. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med 178: 158–167, 2008.
20. Janssen W, Pullamsetti SS, Cooke J, Weissmann N, Guenther A, Schermuly RT. The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis. J Pathol 229: 242–249, 2013.
21. Jensen E, Gundersen H, Osterby R. Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19–33, 1979.
22. Jung A, Allen L, Nyengaard J, Gundersen H, Richter J, Hawgood S, Ochs M. Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice. Anat Rec A Discov Mol Cell Evol Biol 286: 885–890, 2005.
23. Knudsen L, Atochina-Vasserman EN, Guo CJ, Scott PA, Haenni B, Beers MF, Ochs M, Gow AJ. NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis. PLoS One 9: e85722, 2014.
24. Knudsen L, Ochs M, Mackay R, Townsend P, Deb R, Mühlfeld C, Richter J, Gilbert F, Hawgood S, Reid K, Clark H. Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice. Respir Res 8: 70, 2007.
25. Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M. Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol 108: 412–421, 2010.
26. Korfhagen T, Sheftelyevich V, Burhans M, Bruno M, Ross G, Wert S, Stahlman M, Jobe A, Ikegami M, Whitsett J, Fisher J. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 273: 28438–28443, 1998.
27. Lundblad LK, Thompson-Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, Bates JH. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 171: 1363–1370, 2005.
28. Massa CB, Scott P, Abramova E, Gardner C, Laskin DL, Gow AJ. Acute chlorine gas exposure produces transient inflammation and a progressive alteration in surfactant composition with accompanying mechanical dysfunction. Toxicol Appl Pharmacol 278: 53–64, 2014.
29. Massa CB, Allen GB, Bates JH. Modeling the dynamics of recruitment and derecruitment in mice with acute lung injury. J Appl Physiol 105: 1813–1821, 2008.
30. Mühlfeld C, Ochs M. Quantitative microscopy of the lung: a problembased approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract. Am J Physiol Lung Cell Mol Physiol 305: L205–L221, 2013.
31. Naura AS, Zerfaoui M, Kim H, Abd Elmageed ZY, Rodriguez PC, Hans CP, Ju J, Errami Y, Park J, Ochoa AC, Boulares AH. Requirement for inducible nitric oxide synthase in chronic allergen exposureinduced pulmonary fibrosis but not inflammation. J Immunol 185: 3076–3085, 2010.
32. Ochs M. A brief update on lung stereology. J Microsc 222: 188–200, 2006.
33. Ochs M, Knudsen L, Allen L, Stumbaugh A, Levitt S, Nyengaard J, Hawgood S. GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice. Am J Physiol Lung Cell Mol Physiol 287: L1333–L1341, 2004.
34. Ochs M, Mühlfeld C. Quantitative microscopy of the lung: a problembased approach. Part 1: basic principles of lung stereology. Am J Physiol Lung Cell Mol Physiol 305: L15–L22, 2013.
35. Romanska HM, Polak JM, Coleman RA, James RS, Harmer DW, Allen JC, Bishop AE. iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. J Pathol 197: 372–379, 2002.
36. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26: 57–60, 1970.
37. Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, Pardo A. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 279: L562–L574, 2000.
38. Tschanz S, Schneider JP, Knudsen L. Design-based stereology: Planning, volumetry and sampling are crucial steps for a successful study. Ann Anat 196: 3–11, 2014.
39. Tschanz SA, Burri PH, Weibel ER. A simple tool for stereological assessment of digital images: the STEPanizer. J Microsc 243: 47–59, 2011.
40. Wert S, Yoshida M, LeVine A, Ikegami M, Jones T, Ross G, Fisher J, Korfhagen T, Whitsett J. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 97: 5972–5977, 2000.
41. Yoshida M, Korfhagen T, Whitsett J. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 166: 7514–7519, 2001.
42. Zhao Y, Cui A, Wang F, Wang XJ, Chen X, Jin ML, Huang KW. Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema. Chin Med J (Engl) 125: 3015–3021, 2012.